(158 days)
The MOVES™ is a portable computer controlled electrically powered emergency transport ventilator intended to provide continuous or intermittent ventilatory support for the care of adults who require mechanical ventilation.
The MOVES™ is intended to deliver high inspired oxygen concentrations via the MOVES™ O2 mask to spontaneously breathing patients who require elevated inspired oxygen.
MOVESTM is intended to be used in a transport or emergency setting on adult patients who weigh between 40 and 120kg.
MOVES™ provides the following supplemental functions for patients that it is ventilating or to whom it is delivering elevated inspired oxygen:
a. Suction
The MOVES™ suction pump is intended for aspiration and removal of fluids, tissue (including bone), gases, bodily fluids or infectious materials from wounds or from a patient's airway or respiratory support system.
b. Supplementary Oxygen
The MOVESTM is intended to provide supplemental oxygen enriched air to patients that require supplemental oxygen.
C. Patient Monitoring
The MOVESTM is intended to monitor physiological parameters of patients and provide these parameters to a health care provider for interpretation in the form of physiological data and system alarms. Physiological data and system alams will be available to the care provider from the monitor.
The MOVES™ is a portable multifunction patient support and monitoring system with the following capabilities:
- Computer controlled, electrically powered circle ventilator intended to provide . continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
- . Delivery oxygen-enriched air that may be supplied from an external oxygen source or generated internal to the system with the on-board oxygen concentrator.
- Patient monitoring functions including the following patient parameters: Pulse . Rate, Noninvasive BP (NIBP), Invasive BP (IBP), SPO2, Temperature, Respiration Rate, CO2, and O2.
- Suction/aspirator pump for medical suction procedures where secretions, blood . and other body fluids must be removed through the application of continuous negative pressure.
The moves is capable of operating under battery power or external AC supply. It includes a handle and mounting equipment that allows it to attach to a stretcher.
The provided 510(k) summary for the MOVES™ device does not contain specific acceptance criteria in quantitative terms (e.g., minimum sensitivity, specificity, or error rates) or detailed results of a study designed to prove the device meets such criteria. Instead, it relies on a comparison to predicate devices and adherence to recognized standards.
Here's an analysis based on the information provided, outlining what is or isn't present regarding acceptance criteria and performance studies:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state quantitative acceptance criteria for device performance. Instead, it claims substantial equivalence to predicate devices and compliance with various IEC, ISO, ASTM, and ANSI/AAMI standards. The "reported device performance" is described qualitatively as meeting "all of its performance requirements" and being "substantially equivalent" to predicate devices.
| Acceptance Criterion (Implicit/General) | Reported Device Performance (Qualitative) |
|---|---|
| Ventilator characteristics equivalent to predicates | Characteristics are substantially equivalent to predicates. |
| Patient monitoring performance equivalent to predicates | Performance is substantially equivalent to predicates. |
| Ability to deliver supplemental oxygen equivalent to predicates | Ability is substantially equivalent to predicates. |
| Airway suction performance equivalent to predicates | Performance is substantially equivalent to predicates. |
| No unmitigated risks compared to predicate devices | Introduces no unmitigated risks. |
| Compliance with relevant recognized consensus safety and performance standards | Complies with IEC 60601-1, -1-2, -2-27, -2-30, -2-34, -2-49; ISO 21647, 9919; EN-794-3; ASTM E1112-00; ANSI/AAMI EC-13, SP10. |
| EMC, environmental, shock & vibration testing | Performed in accordance with IEC 60601-1-2, EN794-3, MIL-STD-810F. |
2. Sample Size Used for the Test Set and Data Provenance
This information is not provided in the document. The summary refers to "performance testing" but does not detail the methodology, sample sizes (e.g., number of test subjects, test scenarios, or data points), or provenance of any data used in such testing.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This information is not applicable as the document does not describe a study involving expert-established ground truth for a test set. The validation approach is based on demonstrating equivalence to existing devices and compliance with technical standards.
4. Adjudication Method for the Test Set
This information is not applicable as the document does not describe a study requiring a test set with adjudicated ground truth.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done or at least not described in this 510(k) summary. The device is not an AI-assisted diagnostic tool that would typically involve human readers.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done
This concept is not applicable in the context presented. The MOVES™ is a medical device for patient support and monitoring, not an algorithm being evaluated for standalone diagnostic or assistive performance. The "performance testing" mentioned refers to the device's functional operation.
7. The Type of Ground Truth Used
The concept of "ground truth" as typically understood in AI/imaging studies (e.g., pathology, expert consensus) is not directly applicable here. For this type of device, the "ground truth" would be the engineering specifications and performance capabilities of the device as measured against recognized standards and the performance of predicate devices. For example, a ventilation parameter's accuracy would be verified against a reference standard or precision instrument, not an expert opinion.
8. The Sample Size for the Training Set
This information is not provided and is not applicable in the context of this device. The MOVES™ device is not described as utilizing machine learning or AI that would require a "training set" in the conventional sense. Its "computer-controlled" nature implies programmatic logic rather than learned models.
9. How the Ground Truth for the Training Set was Established
This information is not applicable as there is no mention of a "training set" or a machine learning component requiring one.
In summary: The 510(k) process for the MOVES™ device focused on demonstrating substantial equivalence to already cleared predicate devices and compliance with relevant industry standards. The summary does not provide specific quantitative acceptance criteria or detailed results from a clinical or performance study with defined sample sizes, expert involvement, or ground truth establishment in the way one would expect for an AI/diagnostic software submission. The "performance testing" mentioned is general and aimed at confirming functional operation and safety against established standards and predicate device performance.
{0}------------------------------------------------
510(k) SUMMARY
SUBMITTER INFORMATION
MAR 2 6 2010
| Company Name: | Thornhill Research Inc. |
|---|---|
| Company Address: | 70 Peter St., 2nd Fl. |
| Toronto, Ontario | |
| Canada | |
| M5V 2G5 | |
| Company Phone: | (416) 597-1325 |
| Company Fax: | (416) 597-1330 |
Cliff Ansel, President Contact Person:
DEVICE IDENTIFICATION
| Trade/Proprietary Name: | MOVES TM |
|---|---|
| Classification: | II |
| Generic Device Name: | Emergency Ventilator with Suction, Multi-Parameter Patient Monitoring, and oxygen concentrator |
Classification Names
| Classification Name | ProductCode | Class | RegulationNumber |
|---|---|---|---|
| Ventilator, Emergency Powered | BTL | II | 21 CFR 868.5925 |
| Oxygen Concentrator | CAW | II | 21 CFR 868.5440 |
| Patient Monitoring Equipment | MWI | II | 21 CFR 870.2300 |
| Powered Suction Pump | BTA | II | 21 CFR 878.4780 |
| Valve, Non-Rebreathing | CBP | II | 21 CFR 865.5870 |
| Mask, Oxygen, Non-Rebreathing | KGB | II | 21 CFR 868.5570 |
DEVICE DESCRIPTION
The MOVES™ is a portable multifunction patient support and monitoring system with the following capabilities:
- Computer controlled, electrically powered circle ventilator intended to provide . continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
- . Delivery oxygen-enriched air that may be supplied from an external oxygen source or generated internal to the system with the on-board oxygen concentrator.
- Patient monitoring functions including the following patient parameters: Pulse . Rate, Noninvasive BP (NIBP), Invasive BP (IBP), SPO2, Temperature, Respiration Rate, CO2, and O2.
{1}------------------------------------------------
- Suction/aspirator pump for medical suction procedures where secretions, blood . and other body fluids must be removed through the application of continuous negative pressure.
The moves is capable of operating under battery power or external AC supply. It includes a handle and mounting equipment that allows it to attach to a stretcher.
INTENDED USE
Intended Use:
The MOVESTM is a portable computer controlled electrically powered emergency transport ventilator intended to provide continuous or intermittent ventilatory support for the care of adults who require mechanical ventilation.
The MOVESTM is intended to deliver high inspired oxygen concentrations via the MOVESTM O2 mask to spontaneously breathing patients who require elevated inspired oxygen.
MOVES™ is intended to be used in a transport or emergency setting on adult patients who weigh between 40 and 120kg.
- MOVESTM provides the following supplemental functions for patients that it is ventilating or supplying with supplemental oxygen:
- Suction a.
The MOVES™ suction pump is intended for aspiration and removal of fluids, tissue (including bone), gases, bodily fluids or infectious materials from wounds or from a patient's airway or respiratory support system.
b. Supplementary Oxygen
The MOVES™ is intended to provide supplemental oxygen enriched air to patients that require supplemental oxygen.
Patient Monitoring C.
The MOVESTM is intended to monitor physiological parameters of patients and provide these parameters to a health care provider for interpretation in the form of physiological data and system alarms. Physiological data and system alarms will be available to the care provider from the monitor.
{2}------------------------------------------------
SUBSTANTIAL EQUIVALENCE
The MOVES™ is of comparable type and is substantially equivalent to the following predicate devices:
| Device | 510(k) # |
|---|---|
| Sequal Eclipse 2 | K013931 |
| VersaMed iVent 201 | K052554 |
| Univent Eagle 73x | K051476 |
| Univent Eagle 754 | K931473 |
| Hi-Ox80 | K030943 |
| Medela Vario 8 & 18 | K061435 |
| Criticare Poet Plus Patient Monitor (Model 8100) | K012059 |
| Welch Allyn Propaq Encore | K012451 |
Comparison to Predicate Devices
A Comparison of specifications demonstrates that the MOVES is substantially equivalent to the identified devices. The MOVES™ has substantially equivalent intended uses to the predicates. The differences in intended use between MOVES™ and the defined predicates are related to additional restrictions placed on MOVES™. MOVES™ is only intended to be used on adults 40-120kg and in a transport and emergency environment.
The performance specifications of MOVES are substantially equivalent to those of the identified predicate devices. Where differences exist, they raise no concerns about safety and efficacy.
The primary difference between MOVES™ and predicate ventilators is in the use of a circle system to conserve oxygen. Although MOVES™ is intended for transport, this technology is the standard of care for BSZ ventilators such as the Datex Ohmeda 7900 (K081844). All ventilator modes provided by MOVES™ have equivalents among the identified predicates.
The differences in technological characteristics of MOVES™, including the use of a circle system in a transport environment, have been assessed as part of the risk analysis and during performance testing. The MOVESTM meets all of its performance requirements and does not introduce any unmitigated risks when compared to predicate devices.
Differences in technological characteristics between MOVES™ and the identified do not raise any new concerns of safety and efficacy, particularly when reviewed in light of the restrictions MOVESTM places on its target population and intended use environment. This, coupled with the integrated nature of the MOVES™ device, adequately addresses these differences.
{3}------------------------------------------------
Compliance to Standards and Regulations
IEC 60601-1 IEC 60601-1-2 IEC 60601-2-27 IEC 60601-2-30 IEC 60601-2-34 IEC 60601-2-49 ISO 21647 EN-794-3 ISO 9919 ASTM E1112-00 ANSI/AAMI EC-13 ANSI/AAMI SP10
Summary of Performance Testing
Safety and performance testing was conducted in accordance with all referenced standards and regulations, and to validate all system requirements. EMC, environmental, and shock and vibration testing was conducted in accordance with IEC 60601-1-2, EN794-3 and MIL-STD-810F.
The results of performance testing demonstrate that the characteristics of MOVES are substantially equivalent to the identified predicates in terms of ventilator characteristics, patient monitoring performance, ability to delivery supplemental oxygen, and provide airway suction.
Determination of Substantial Equivalence
The MOVESTM system is substantially equivalent to the predicate devices. Where differences in performance or technology exist, it has been demonstrated that they do not adversely impact safety or effectiveness. In addition, MOVESTM has been tested to comply with relevant recognized consensus safety and performance standards as well as voluntary standards (detailed above). The combination of performance verification testing and testing to applicable objective standards substantiates the claim of substantial equivalence and the safety and efficacy of the MOVESTM system.
Conclusions:
The MOVES is substantially equivalent to the identified predicate devices and does not raise any new concerns about safety and efficacy.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three human profiles embedded within its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird image.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
Mr. Cliff Ansel President & Chief Executive Office Thornhill Research, Incorporated 70 Peter Street 2nd Floor Toronto, Ontario Canada M5V 2G5
MAR 2 6 2010
Re: K093261
Trade/Device Name: MOVESTM Regulation Number: 21CFR 868.5925 Regulation Name: Powdered Emergency Ventilator Regulatory Class: II Product Code: BTL Dated: March 22, 2010 Received: March 23, 2010
Dear Mr. Ansel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract hability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
, .
{5}------------------------------------------------
Page 2- Mr. Ansel
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Indications for Use Statement
510(k) Number (if known): Not Known
Device Name: MOVES™
The MOVES™ is a portable computer controlled electrically powered emergency transport ventilator intended to provide continuous or intermittent ventilatory support for the care of adults who require mechanical ventilation.
The MOVES™ is intended to deliver high inspired oxygen concentrations via the MOVES™ O2 mask to spontaneously breathing patients who require elevated inspired oxygen
MOVESTM is intended to be used in a transport or emergency setting on adult patients who weigh between 40 and 120kg.
MOVES™ provides the following supplemental functions for patients that it is ventilating or to whom it is delivering elevated inspired oxygen:
- a. Suction
The MOVES™ suction pump is intended for aspiration and removal of fluids, tissue (including bone), gases, bodily fluids or infectious materials from wounds or from a patient's airway or respiratory support system.
Supplementary Oxygen b.
The MOVESTM is intended to provide supplemental oxygen enriched air to patients that require supplemental oxygen.
Patient Monitoring C.
The MOVESTM is intended to monitor physiological parameters of patients and provide these parameters to a health care provider for interpretation in the form of physiological data and system alarms. Physiological data and system alams will be available to the care provider from the monitor.
Prescription Use AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
{7}------------------------------------------------
Operating Environment
MOVES™ is intended to be operated in a transport or emergency setting.
Target Population
The intended patient population is adult patients who weigh between 40 and 120 kg.
L. Arbetta
(Division Sign-Off) Division of Anesthesiology, General Hospital infection Control, Dental Devices
510(k) Number: K093261
CONFIDENTIAL AND PROPRIETARY INFORMATION OF THORNHILL RESEARCH INC.
§ 868.5925 Powered emergency ventilator.
(a)
Identification. A powered emergency ventilator is a demand valve or inhalator intended to provide emergency respiratory support by means of a face mask or a tube inserted into a patient's airway.(b)
Classification. Class II (performance standards).